Literature DB >> 10190738

Expression and processing of gastrin in hepatocellular carcinoma, fibrolamellar carcinoma and cholangiocarcinoma.

M Caplin1, K Khan, K Savage, J Rode, A Varro, D Michaeli, S Grimes, B Brett, R Pounder, A Dhillon.   

Abstract

BACKGROUND/AIMS: Gastrin is a trophic factor within the normal gastrointestinal tract and is also a mitogen for a number of gastrointestinal and non-gastrointestinal tumours. Precursor forms of gastrin including progastrin (proG) and glycine-extended gastrin (G-gly) as well as the fully processed amidated gastrin (G-NH2) are expressed by tumours. There has been little study of the role of gastrin in either normal liver or liver tumours. The aim of this study was to identify the expression of CCK-B/gastrin receptor (CCK-BR), proG, G-gly and G-NH2 in normal liver and liver tumours.
METHODS: Tissue sections from patients with hepatocellular carcinoma, fibrolamellar carcinoma, cholangiocarcinoma as well as normal liver biopsies were assessed for expression of CCK-BR and gastrin isoforms.
RESULTS: Most liver tumours express CCK-BR and are able to process gastrin as far as proG and G-gly, although not as far as the amidated form. There appears to be little expression of the receptor and no expression of precursor forms of gastrin in normal liver.
CONCLUSIONS: Liver tumours express the CCK-BR and precursor forms of gastrin. This expression may be associated with tumour proliferation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10190738     DOI: 10.1016/s0168-8278(99)80114-7

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  18 in total

1.  In vivo analysis of mouse gastrin gene regulation in enhanced GFP-BAC transgenic mice.

Authors:  Shigeo Takaishi; Wataru Shibata; Hiroyuki Tomita; Guangchun Jin; Xiangdong Yang; Russell Ericksen; Zinaida Dubeykovskaya; Samuel Asfaha; Michael Quante; Kelly S Betz; Arthur Shulkes; Timothy C Wang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-11-04       Impact factor: 4.052

2.  Effect of gastrin and anti-gastrin antibodies on proliferation of hepatocyte cell lines.

Authors:  M Caplin; K Khan; S Grimes; D Michaeli; K Savage; R Pounder; A Dhillon
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

3.  Effects of cyclooxygenase-2 inhibition on serum and tumor gastrins and expression of apoptosis-related proteins in colorectal cancer.

Authors:  Peter C Konturek; Kazimierz Rembiasz; Grzegorz Burnat; Stanisław J Konturek; Marcin Tusinela; Władysław Bielanski; Jens Rehfeld; Danuta Karcz; Eckhart Hahn
Journal:  Dig Dis Sci       Date:  2006-04       Impact factor: 3.199

4.  Gastric autoimmune disorders in patients with chronic hepatitis C before, during and after interferon-alpha therapy.

Authors:  Carlo Fabbri; M Francesca Jaboli; Silvia Giovanelli; Francesco Azzaroli; Alessandro Pezzoli; Esterita Accogli; Stefania Liva; Giovanni Nigro; Anna Miracolo; Davide Festi; Antonio Colecchia; Marco Montagnani; Enrico Roda; Giuseppe Mazzella
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

5.  Detection of anti-HAV antibody with dot immunogold filtration assay.

Authors:  Zhong-Jun Shao; De-Zhong Xu; Yong-Ping Yan; Jing-Hua Li; Jing-Xia Zhang; Zhi-Ying Zhang; Bo-Rong Pan
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

6.  Proton pump inhibitors and risk of liver cancer and mortality in patients with chronic liver disease: a systematic review and meta-analysis.

Authors:  Hyun Jin Song; Xinyi Jiang; Linda Henry; Mindie H Nguyen; Haesuk Park
Journal:  Eur J Clin Pharmacol       Date:  2020-03-14       Impact factor: 2.953

7.  Immunohistochemical examination of gastrin, gastrin precursors, and gastrin/CCK-2 receptor in human esophageal squamous cell carcinomas.

Authors:  Aping Yuan; Jinzhong Liu; Yiqing Liu; Tone Bjørnsen; Andrea Varro; Guanglin Cui
Journal:  Pathol Oncol Res       Date:  2008-04-26       Impact factor: 3.201

8.  Progastrin and cyclooxygenase-2 in colorectal cancer.

Authors:  Peter C Konturek; Władysław Bielanski; Stanislaw J Konturek; Artur Hartwich; Piotr Pierzchalski; Macien Gonciarz; Krzysztof Marlicz; Teresa Starzynska; Monika Zuchowicz; Zbigniew Darasz; Jens P Götze; Jens F Rehfeld; Eckhart G Hahn
Journal:  Dig Dis Sci       Date:  2002-09       Impact factor: 3.199

9.  Signaling through cholesterol esterification: a new pathway for the cholecystokinin 2 receptor involved in cell growth and invasion.

Authors:  Michael R Paillasse; Philippe de Medina; Guillaume Amouroux; Loubna Mhamdi; Marc Poirot; Sandrine Silvente-Poirot
Journal:  J Lipid Res       Date:  2009-06-05       Impact factor: 5.922

10.  Pituitary protein 7B2 plasma levels in patients with liver disease: Comparisons with other hormones and neuropeptides.

Authors:  Maria S Venetikou; Luke Meleagros; Mohhammad A Ghatei; Stephen R Bloom
Journal:  Oncol Lett       Date:  2013-06-07       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.